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Key messages: Identifying geographical variation in dementia prevalence and incidence could 
lead to the identification of potentially modifiable risk—or protective—factors. This review 
identifies evidence, based on within-study comparisons, at a variety of scales of geographical 
variation of dementia. Furthermore, there is evidence from meta-analysis of an association 
between rural living and AD, particularly for early life rural living. 
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SUMMARY 
Background: Geographical variation in dementia prevalence and incidence may indicate 
important socio-environmental contributions to dementia aetiology. However previous 
comparisons have been hampered by combining studies with different methodologies. This 
review systematically collates and synthesises studies examining geographical variation in the 
prevalence and incidence of dementia based on comparisons of studies using identical 
methodologies. 
Methods: Papers were identified by a comprehensive electronic search of relevant databases, 
scrutinising the reference sections of identified publications, contacting experts in the field and 
re-examining papers already known to us. Identified articles were independently reviewed against 
inclusion/exclusion criteria and considered according to geographical scale. Rural/urban 
comparisons were meta-analysed. 
Results: Twelve thousand, five hundred and eighty records were reviewed and fifty eight articles 
were included. Dementia prevalence and incidence varies at a number of scales from the national 
down to small areas, including some evidence of an effect of rural living (prevalence OR 1.11, 
90% CI 0.80, 1.53; incidence OR 1.20, 90% CI 0.84, 1.71). However this association of rurality 
was stronger for Alzheimer disease, particularly when early life rural living was captured 
(prevalence OR 2.22, 90% CI 1.19, 4.16; incidence OR 1.64, 90% CI 1.08, 2.50). 
Conclusions: There is evidence of geographic variation in rates of dementia in affluent countries 
at a variety of geographical scales. Rural living is associated with an increased risk of Alzheimer 
disease and there is a suggestion that early-life rural living further increases this risk. However few 
studies in resource-poor countries limits conclusions. 
 
MeSH Keywords : Dementia; Alzheimer disease; Epidemiology; Geography; Disease Clustering
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INTRODUCTION 
Tobler’s first law of geography states that the relationship between entities is stronger when they 
are close than when they are distant.1 In epidemiology, this is equally true for disease occurrence: 
clustered areas of low or high incidence may implicate environmental exposures associated with 
the disease and this may have important public health consequences. Leukaemia demonstrates 
geographical clustering that may be related to proximity to nuclear facilities.2, 3 Similarly the 
worldwide variation in multiple sclerosis rates suggests a complex interplay of genetic and 
environmental factors such as climate, diet, geomagnetism, toxins and infection.4-6 Clustering in 
both space7, 8 and space-time9 in schizophrenia has been described. While systematic reviews of 
geographical variation in dementia exist,10-12 previous aggregations of the evidence have relied on 
the ad hoc comparison of dementia occurrence across studies focusing on contrasting geographic 
locations (e.g., different countries or urban and rural areas).  
 
However data from a single study in one geographical location cannot be directly compared with 
another single centre study from another location because methodological differences between 
the studies, for example differing diagnostic criteria or the way they are operationalised, may 
produce artefactual differences in prevalence or incidence. Accordingly, we provide an update of 
this evidence together with meta-analysis examining geographical variation in the prevalence and 
incidence of dementia from within-study comparisons. 
 
METHOD 
Information sources 
We adopted a four-pronged approach to identifying relevant studies.  First, we conducted an 
electronic search of relevant databases.  Second, we scrutinised the reference sections of 
identified publications.  Third, we contacted experts in the field.  Fourth, we re-examined papers 
already known to us. Searches were conducted by an Information Scientist (CF). Table 1 shows 
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databases utilised, with dates. Comprehensive search criteria were developed iteratively. The full 
electronic search strategies for all databases used, including limits applied, are reported in the 
appendix. Results of the literature search were independently screened in parallel by two 
reviewers (TR and GH). Abstracts of relevant titles were reviewed and the full text of each 
highlighted article was obtained. 
 
Eligibility criteria 
Inclusion criteria were: cross-sectional and longitudinal studies of any length offering a 
comparison of dementia prevalence or incidence between two or more different sites, at any 
geographical scale. Grey literature and theses were included. We did not limit the search by 
language (as long as there was an English language abstract) with the intention of having relevant 
papers translated. We also included papers in languages other than English if other reports from 
the same study had been published in English to allow adequate assessment of the methodology 
and this further report contained relevant data. Papers could consider all causes of dementia apart 
from those secondary to external causes or where dementia is a later, secondary feature of the 
disorder, e.g. alcohol or traumatic brain injury, Parkinson’s disease, Huntington’s disease and 
Creutzfeld Jakob Disease, either sporadic or variant.  
 
Exclusion criteria were: papers comparing studies using external comparison groups, which were 
conducted independently or which used different methodologies (for example, the 
EURODEM/EuroCoDe papers13-16 or other ‘quantitative integrations of the literature’10); studies 
with no spatial variable—e.g. comparing different ethnic groups or investigating aluminium or 
silicate concentrations in water; and references with no abstract and a vague title (e.g. 
‘epidemiology of dementia’). Studies focussing purely on young onset dementia were excluded in 
order to reduce heterogeneity in the review. 
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A large number of papers describe the clusters of amyotrophic lateral sclerosis/parkinsonism-
dementia complex in the Pacific basin. This cluster was included since the condition is 
prominently characterised by dementia. Due to the wealth of literature describing these isolated 
clusters a representative paper was selected for inclusion. 
 
Data collection 
The principal summary measure was the prevalence or incidence of dementia in the two (or 
more) areas studied. Other data collected were the scale of comparison or areas which were 
compared, methods (including diagnostic criteria) and measures used, details and number of 
participants, including ages. The studies were also assessed for quality of design and methodology 
from A (best) to E (worst), including a consideration of bias. This measure of quality took into 
account quality and limitations of case-finding procedures, diagnostic criteria used, 
standardisation across sites and completeness of follow up in longitudinal studies.  
Estimates of error were not reported by all authors, limiting the precision of comparisons of 
reported prevalence or incidence rates. Where possible, reported p values were converted to 95% 
confidence intervals (CI).17  
 
Meta-analysis 
Numbers of cases and non-cases in studies comparing prevalence or incidence of dementia in 
rural and urban areas were used to compute odds ratios (OR) with accompanying 90% CIs, in 
line with statistical guidance.18 Urban areas formed the referent in all models. Where raw 
numbers were not reported, odds ratios and 95% CIs were converted to log odds ratios and log 
variances. These study-specific estimates of prevalence and incidence were meta-analysed, using 
random-effects models since there was a large amount of heterogeneity (prevalence studies: I2 
89.5%; incidence studies: I2 81.2%). Authors of studies reporting insufficient data19-21 were 
contacted, apart from Leighton et al.22 for whom contact details were unavailable.  
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Sensitivity analyses 
One prevalence study classified participants according to more than one set of diagnostic 
criteria.23 In the main analyses, the results using DSM-IV criteria were used. We also examined 
the effect of altering the diagnostic criteria used and the effect of excluding the study completely 
from the models. We conducted a further sensitivity analysis stratifying the prevalence and 
incidence meta-analyses by study quality. 
 
Statistical analyses were conducted using R version 2.15.024 and the metafor package.25 Figures 3 
and 4 were drawn with the R package Rmeta.26 The reporting of this systematic review conforms 
to the PRISMA statement.27 
 
RESULTS 
A total of twelve thousand, five hundred and eighty records were screened and the two reviewers 
(TR & GH) produced shortlists of one hundred and sixty four and one hundred and seventy 
three papers, respectively, that potentially matched inclusion criteria.  Of these one hundred and 
twelve studies were excluded (reasons for exclusion are outlined in Figure 1 which shows the 
screening process) leaving fifty two articles (from thirty five unique studies) which are 
summarised in Tables 2-6. 
 
The studies included were conducted across the world, though predominantly in high-income 
countries (Europe, Canada and the USA). The studies ranged in size from three hundred and 
twenty one28 to the entire population of the USA.29 Methodologies included multiple-phase 
population surveys (n=2319, 21, 30-50), one-phase surveys (n=1222, 23, 28, 51-59), using death certificate 
data (n=920, 29, 49, 60-65), and case registers (n=866-72). Twelve studies included a longitudinal design 
allowing dementia incidence to be ascertained.19, 31, 33-35, 38-41, 43, 58, 59 
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Diagnostic criteria used included the International Classification of Diseases (ICD), ninth 
revision73 (n=720, 53, 59, 63, 68-70) or  ICD-1074 (n=1135-37, 42, 43, 46, 47, 50, 60, 62, 65), the third edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-III75 or DSM-III-R76; n=1332-36, 39, 42-
45, 48, 49, 52) or DSM-IV77 (n=719, 23, 46, 47, 50, 57, 58). Twelve studies did not state the diagnostic criteria 
they used.21, 22, 30, 31, 33, 34, 38-41, 61, 64 Tests used included the Mini Mental-State Examination78 (MMSE) 
in various languages (n studies=919, 21, 30, 31, 37, 38, 40, 41, 46, 47, 49-51), the modified MMSE79, 80 (3MS; 
n=4,32-34, 39 all part of the Canadian Study of Health & Aging), the Community Screening 
Instrument for Dementia81 (CSID; n=435, 36, 42, 43, all part of the Ibadan-Indianapolis study), the 
cognitive part of the Cambridge Examination for Mental Disorders of the Elderly 82 (CAMCOG; 
n=431, 40, 41, 50), the Comprehensive Assessment and Referral Evaluation (Care) or short-Care 
interview83 (n=228, 54) and the Mental Status Questionnaire84  (MSQ) or Short Portable MSQ85 
(n=228, 59). Three studies31, 40, 41, 52, 55, 56 used the Geriatric Mental Schedule (GMS) and the 
Automated Geriatric Examination for Computer Assisted Taxonomy86, 87 (AGECAT). Twenty-
three studies included a clinical assessment of participants.19, 21, 30, 32-39, 42-49, 58, 66, 67, 71 
 
The papers included in the review were divided into groups reflecting the scale of comparison. 
Each group will be considered in turn, comparing rates between countries or nationwide surveys, 
rural and urban areas, regions, towns or cities and smaller areas. 
 
Country-by-country comparisons or nationwide surveys 
Table 2 summarises the results of studies identified which compared rates of dementia between 
countries. There were two main methodologies used at this scale: comparing mortality rates (of 
the whole population or a sample) between two or more countries, and identifying the country of 
birth of individuals in a discrete area in a single country. 
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Age-adjusted Alzheimer disease (AD) mortality in 1999 was reported as 15.9% in the USA 
compared to 21.2% in Puerto Rico.60 Rates for 2004 were 20.9% and 32.4%, respectively. They 
conjectured that the increase in dementia rates might be explained by improved survival. 
 
The “Colombo 2000” project found disease-specific mortality rates for AD to be higher in Italy 
(9.8/10 000) than in Argentina, which has a large Italian immigrant population (3.4/10 000).64, 88 
Another study comparing random samples of the over-60s found that the proportion scoring less 
than twenty out of thirty on the MMSE was 4.5% in Argentina, 9.4% in Chile and 7.2% in 
Cuba.51 With a higher cut-off of twenty two or less out of thirty, the proportions were Argentina 
4.5%, Chile 19.7% and Cuba 16%. 
 
The 10/66 Dementia Research Group focuses particularly on the under-researched (and 
therefore resource-poor) areas of the world.23, 57 The authors found a much lower prevalence of 
dementia by DSM-IV than by 10/66 consensus criteria in India (rural and urban) and Peru (rural 
only) (Figure 2). Dementia prevalence was found to vary between countries, although the 
directly-standardised prevalence rates differed with the diagnostic criteria used: compared to 
other sites prevalence of dementia was higher in Cuba (10/66 criteria: 12.6%, 95% CI 10.4-14.9; 
DSM-IV: 6.3%, 95% CI 5.0, 7.7) and the Dominican Republic (10/66: 9.8%, 95% CI 8.1-11.1; 
DSM-IV: 4.2%, 95% CI 3.3, 5.1) and lower in rural China (10/66: 4.8%, 95% CI 3.1, 6.4), rural 
Peru (DSM-IV: 0.4%, 95% CI 0.0, 1.0) and both rural (DSM-IV: 0.3%, 95% CI 0.1, 0.5) and 
urban India (DSM-IV: 0.9%, 95% CI 0.3, 1.6). 
 
The remaining studies used the second methodology mentioned above—identifying the country 
of birth of individuals in a single area, thus providing insight into the effect of place of birth on 
the risk of developing dementia. The Islington study interviewed house-to-house and grouped 
the over-65s by country of birth.54 They found no relation between migration per se and dementia. 
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However the relative risk for developing dementia did vary by place of birth, being lower in the 
Irish population (RR 0.36, 95% CI 0.15, 0.87) and higher in the case of people born in Africa or 
the Caribbean (RR 1.72, 95% CI 1.06, 2.81) when compared to British-born residents. Another 
London-based study found a higher dementia prevalence in African-Caribbean-born residents of 
Haringey compared to the White UK-born population (OR=3.07, 95% CI 1.28–7.32).50  
 
Rural/Urban comparisons 
Table 3 outlines publications comparing rates of dementia in rural and urban areas. The 
rural/urban comparisons were quantitatively examined by meta-analysis where possible with the 
remaining studies being summarised narratively. 
 
Papers which reported (or provided) sufficient prevalence21, 23, 30, 37, 40, 42, 47, 49, 67 or incidence19, 34, 40, 43 
data were meta-analysed using random-effects models and results are shown in Figures 3 and 4 
respectively. Urban areas form the reference group throughout. Out of the authors contacted, 
two replied providing data for inclusion in the meta-analysis.19, 21 Two articles were excluded due 
to reporting insufficient data.20, 22 The latest report from the 10/66 Dementia Research Group 
was excluded because it did not give sufficient data for inclusion despite reporting a slightly later 
stage of the study.57  
 
There was evidence of an association between rurality and prevalence of AD37, 42, 47, 67 (OR 1.50, 
90% CI 1.33, 1.69) and vascular dementia37, 47 (OR 1.33, 90% CI 1.10, 1.62). Evidence was weaker 
for an association between rurality and non-specific dementia prevalence21, 23, 30, 37, 40, 49 (OR 0.91, 
90% CI 0.58, 1.41). Pooling all prevalence studies regardless of diagnostic subtype21, 23, 30, 37, 40, 42, 47, 
49, 67 resulted in an intermediate risk of dementia (OR 1.11, 90% CI 0.80, 1.53). 
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Only one prevalence study classified participants according to more than one set of diagnostic 
criteria.23 Altering the criteria used had a substantial effect on the association between non-
specific dementia and rurality: using DSM-IV criteria OR 0.91 (90% CI 0.58, 1.41); using 10/66 
consensus criteria OR 1.13 (90% CI 0.81, 1.56); and excluding the four comparisons reported in 
this study: OR 1.39 (90% CI 0.75, 2.23). Combining all prevalence studies regardless of 
diagnostic subtype showed a similar pattern: DSM-IV OR 1.11 (90% CI 0.80, 1.53); 10/66 OR 
1.25 (90% CI 0.97, 1.61); and excluding the study OR 1.44 (90% CI 1.03, 2.01). 
 
Stratifying prevalence studies by quality reduced the association between rurality and dementia 
(Studies rated D or better:21, 23, 37, 40, 42, 47, 49, 67 OR 1.15, 90% CI 1.02, 1.71; C or better:23, 37, 40, 42, 47, 49, 67 
OR 1.03, 90% CI 0.80, 1.32; B or better:23, 37, 40, 42, 47 OR 0.95, 90% CI 0.69, 1.29) apart from the 
two comparisons from the one study rated A for quality42 which captured early life rural living in 
which there was an increased association between rurality and AD (OR 2.22, 90% CI 1.19, 4.16). 
 
There was evidence of an association between rurality and dementia incidence19, 34, 40, 43 (OR 1.20, 
90% CI 0.84, 1.71), stronger for AD43 (OR 1.64, 1.08, 2.50) than for non-specific dementia19, 34, 40 
(OR 1.01, 90% CI 0.64, 1.60). Restricting the meta-analysis to incidence studies rated A for 
quality19, 43 (no incidence study was rated lower than B) had little effect on the association with 
rurality (OR 1.17, 90% CI 0.66, 2.06). 
 
19, 43 There was no evidence of publication bias on formal testing (regression test for funnel plot 
asymmetry: prevalence studies z = -1.35, p = 0.18; incidence studies z = 1.51, p = 0.13). 
 
Among the studies reporting insufficient data for meta-analysis a study examining all Japanese 
death certificates from 1979-1990 found that the AD mortality was similar for rural and urban 
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areas20 and a study in Nigeria found that prevalence of ‘chronic brain syndrome’ did not vary 
between Yoruba villages and a nearby town in men (6%) but did in women (5% vs 9%).22 
 
Regional comparisons 
‘Region’ here refers to an area within a country larger than a town or city. Table 4 summarises the 
results of studies identified which compared rates of dementia between regions.  
 
The Canadian Study of Health & Aging reported a similar prevalence of dementia across Canada 
but suggested that the relative prevalence of dementia subtypes varied across regions.32-34 
Particularly low prevalence of dementia in Ontario males was explained by discrepancies in the 
use of diagnostic criteria.32 Another Canadian study concluded that dementia prevalence varies 
little across regions.39 They did note differences between community and institutional samples 
and noted that dementia prevalence was higher in areas of lower socio-economic status. In rural 
Manitoba, Canada, the prevalence of dementia among the Cree was found to be the same as a 
non-Native sample in Winnipeg but there was just one case of AD identified in the Cree (0.5%) 
compared to 20 in the Winnipeg sample (8.3%; age-adjusted rate 3.5%, 95% CI 2.1, 4.8; p < 
0.001).48  
 
A comparison of all dementia deaths in 1999/2000 and 2005/6 across the USA at the county 
level showed a pattern of marked variation in dementia and AD mortality different to that of 
cardiovascular disease and stroke.65 Three “co-operative longitudinal studies” in the USA 
reported 6-year incidence rates of 29.8% in East Boston, 25.0% in New Haven and 20.4% in 
Iowa.59 Using stricter criteria reduced the variation between sites (East Boston 15.4%, New 
Haven 14.3%, Iowa 11.3%). Prevalence of AD in South Carolina showed “notable variation” at a 
county level.68-70 However, it was unclear whether the location was where the individual was born 
or where they were lived as an adult. Clustering of AD deaths in the north-west and south-east of 
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the USA with a four-fold difference in rates between the highest and lowest was identified over 
the period 1999-2004.29 A study in Puerto Rico noted variation in mortality rates with dementia 
in the eight regions of the island.60 
 
The amyotrophic lateral sclerosis/parkinsonism-dementia complex clusters in the Chamorro 
population of Guam (one of the Mariana Islands in the western Pacific Ocean) and elsewhere 
have been extensively studied.89 A representative study on Guam identified an incidence gradient, 
with higher prevalence in southern and central Guam and lower prevalence in northern and 
western Guam.72, 90 More recent reports have not focussed directly on the geographical spread of 
cases.91 There have been suggestions that this cluster could be related to the consumption of a 
palm, Cycas micronesica, but this has not been definitively proven.92 Similar clusters have been 
described on the Kii peninsula of Japan—with prevalence in two villages approximately one 
hundred times that in the rest of the country93—and in West New Guinea.94 
 
An examination of Australian death certificates revealed a much higher prevalence of dementia at 
death in Tasmania and ‘senility’ in South Australia than the rest of the country. 63 Dementia 
prevalence at death was predominantly related to place of death but those who were born and 
died in Tasmania had the highest rate of all. In Tasmania, 43% of dementia death certificates 
were linked to a single practitioner. 
 
A Japanese study found that AD mortality varied across the country with Miyazaki prefecture 
approximately double and Okinawa approximately half the overall national rate.20 Across four 
areas of China, a north-south gradient in dementia prevalence, particularly for vascular dementia, 
and a less pronounced east-west gradient were identified.46, 47  
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The MRC Cognitive Function and Ageing study concluded that there was no evidence of 
variation in incidence or prevalence of dementia in England and Wales.31, 40, 41 The incidence of 
dementia in a working class, urban area of Spain was double that in both the agricultural and 
professional class urban areas.19 A Finnish study found a higher prevalence of AD in the north 
and east of the country than elsewhere.44, 45  
 
Town/City comparisons 
Table 5 outlines the papers comparing rates of dementia between towns and cities. 
 
The Ibadan-Indianapolis study identified a higher age-adjusted prevalence of dementia in 
Indianapolis, USA (4.82%) compared to Ibadan, Nigeria (2.29%; AD 3.69% vs 1.41%).36, 42At 
follow-up, age-standardised annual dementia incidence rates were higher in Indianapolis (3.24%, 
95% CI 2.11, 4.38; Ibadan 1.35%, 95% CI 1.13, 1.56), as were age-standardised annual AD 
incidence rates (Indianapolis 2.52%, 95% CI 1.40, 3.64; Ibadan 1.15%, 95% CI 0.96, 1.35).35, 43 
 
The rates of dementia in the institutionalised elderly with moderate or severe dementia in New 
York and London were found to be similar.28 A later study found that rates of organic illness 
were higher in New York for both men (5.7%; London 2.2%) and women (10.1%; London 
5.4%).52 
 
In Okinawa, there was some evidence of variation in rates of dementia between Sashiki village 
and Ikema island but these were not formally compared and used an idiosyncratic case 
classification.53 
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No difference in dementia prevalence was found between Zaragoza, Spain and Liverpool.55, 56 
Furthermore they identified no sex or age differences. The 3C study found no differences in the 
distribution of cognitive test scores in three cities across France.58  
 
Small area comparisons 
Large-scale (or small area) comparisons are potentially the most informative with regard to 
identifying socio-environmental risk factors for dementia. Table 6 outlines the papers making 
such comparisons.  
 
Death certificates for the over-70s were examined in Newfoundland, Canada and two areas had 
substantially higher dementia mortality rates.61 An excess of individuals born on the north shore 
of Bonavista Bay dying with dementia was identified (14.3%; south shore 2.9%). This was not 
related to differential survival or sex-distribution but may have been affected by kinship and 
migration. Projet IMAGE found no real variation in standardized prevalence rates of dementia in 
an area of Québec, Canada, despite a trend in two areas.66, 67, 71 A Swiss study identified a dose-
response relationship between the length of time living within 50m of a power line and 
developing AD. 62  
 
DISCUSSION 
Main findings 
All published studies indicate that the prevalence and, in one case, incidence of dementia varied 
between countries but the precision of estimates was not always clear. Comparing rural and 
urban areas, there was evidence for an association between rurality and prevalence and incidence 
of AD and prevalence of vascular dementia. The association with AD prevalence was increased 
in studies which captured early life rural living. There was less evidence for an association with 
prevalence or incidence of a general category of dementia. At a regional level, the findings were 
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mixed with some,31-34, 40, 41 but not all,19 of the better quality studies suggesting that there is little 
evidence of variation in dementia prevalence or incidence. However very few studies report data 
supporting their findings, limiting the certainty of conclusions.  
 
There were fewer studies at larger scales and so conclusions must be tentative. However, the best 
quality studies did find variation in dementia incidence between towns/cities.35, 36, 42, 43 The 3C 
study58 did not but reported the distribution of cognitive test scores rather than actual diagnoses 
of dementia. At the most informative (i.e. smallest) scale, there were fewest studies. However all 
except for Projet IMAGE66, 67, 71 found evidence of variation in dementia prevalence. There were 
no studies of dementia incidence at this scale.  
 
To summarise, there is evidence, at all scales, of geographical variation in the prevalence or 
incidence of dementia and, specifically, a higher risk of AD and vascular dementia in rural areas. 
At first glance, the different patterns seen at different scales seem contradictory and confusing. 
However this is a common finding with geographical data, the modifiable areal unit problem where, 
“if the spatial units in a particular study were specified differently, we might observe very 
different patterns and relationships.”95 Unfortunately none of the included studies collected their 
data or conducted their analyses at more than one scale, which might shed some light on this 
ubiquitous problem of spatial data. 
 
The definition of rurality 
There was substantial heterogeneity in the studies comparing rural and urban areas. This is likely 
to be due, at least in part, to the notoriously difficult definition of ‘rurality.’ A Japanese study 
defined an administrative unit as ‘rural’ if the population numbered thirty thousand  or fewer.20 In 
Sicily, the isolation of rural Troina (where the “economy is almost completely based on farming 
and grazing.”) is contrasted with the urban area “connected by rail, sea, a regional road, and a 
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motorway… [where] the economy is more diversified.”.30 The 10/66 Dementia Research Group 
defined rural areas “by low population density, and traditional agrarian lifestyle.”96 Projet IMAGE 
defined a rural area as containing villages rather than cities.97, 98 Nevertheless it is surprising how 
many studies do not explicitly define rurality—for example neither Liu et al38 nor investigators in  
the Canadian Study of Health & Aging 32, 34, 99  provided a definition of rurality. This is easier to 
understand when comparing extremes, for example a large city and distant villages, when the 
difference is obvious. However, it becomes more difficult to make subtle distinctions. Indeed a 
perfect definition may remain elusive and the epidemiological importance may not lie in the 
contrast but, rather, in the optimum population density (as has been demonstrated for 
cardiovascular disease and stroke in men100) and access to health services and factors conducive 
to a healthy lifestyle.  
 
Young-onset dementia 
While studies purely examining young-onset dementia were excluded from this review, there are a 
number of relevant studies which echo the findings in late-onset dementia. A study in Israel—
using country of birth as the spatial variable—found age- and sex-adjusted incidence rates for 
European-American-born individuals to be double that of African-Asian-born people.101 At a 
larger scale, a study in Edinburgh identified all 55 unrelated cases of young-onset AD admitted to 
hospital and noted high prevalence in two geographical areas.102 A subsequent study of young-
onset dementia across the whole of Scotland looked at the geographical distribution of cases and 
found non-random distribution of cases of young-onset AD but not vascular dementia.103-106 This 
pattern was partly, but not entirely, explained by kinship, suggesting that socio-environmental 
factors may also play a role in the aetiology of young-onset dementia.104 
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Limitations of the review and risk of bias within and across studies  
The methodology of this review was systematic and robust and the wide, professionally-
conducted search and two independent reviewers are likely to have identified all the available 
literature.  
 
There is the possibility that variation in dementia prevalence or incidence might be the result of 
chance but this review includes a large number of studies, many of them methodologically 
robust, which have found variation, suggesting that chance is unlikely to be behind all of them. 
Furthermore all the studies included in the review offer within-study comparisons minimising the 
possibility that identified variations in prevalence or incidence are the result of methodological 
differences between studies. 
 
The first and most profound limitation to and source of bias in this review is the lack of attention 
paid to epidemiological studies of dementia in large areas of the world,107 a point noted and 
beginning to be remedied by bodies such as the 10/66 Dementia Research Group,23, 57 but also 
highlighted recently in relation to studies in Eastern and Middle European Countries.16 This is 
particularly important since it is predicted that increases in dementia prevalence will be larger in 
the developing world than elsewhere.107, 108 Until there are good quality epidemiological studies 
across the world, no conclusions regarding the global variation of dementia can be any less than 
conjectural. 
 
There are significant methodological difficulties involved when comparing epidemiological 
studies, such as the method and thoroughness of case-finding,10 whether the entire population or 
a sample will be studied109 and the choice of study setting itself. These difficulties are 
compounded in studies of dementia by consideration of different diagnostic criteria and whether 
or not to include mild cases,10 let alone individuals with ‘mild cognitive impairment.’ Further 
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biases such as differential survival and consequent differing age structures of populations, 
variation in diagnosis rates and reporting of dementia,63, 110 screening non-participation and 
validation,111 access to health care and levels of health and education make conducting and 
interpreting such studies—even when they are methodologically identical—extremely difficult.11 
These challenges are likely to have produced some bias in the studies and are reflected in the 
variation in quality ratings for the studies. One interesting finding from two studies51, 59 is that 
geographical variation reduces with stricter diagnostic criteria confirming Jorm’s assertion that 
the inclusion or exclusion of milder cases can have an important effect on the findings of 
quantitative studies of dementia.10 
 
Thinking further about diagnostic criteria, no studies investigated definitive neuropathological 
diagnoses and so differential rates of dementia sub-types must be considered no more certain 
than ‘probable,’ in line with diagnostic criteria.112-116 Therefore the possibility remains that the 
clinical diagnoses reported in these studies may not perfectly reflect neuropathology, as has been 
shown previously.117, 118 The common neuropathological finding of mixed pathologies further 
complicates matters. This suggests that conclusions regarding specific dementia subtypes should 
be considered tentative. 
 
A large number of studies rely on case registers or death certificate data. These methodologies are 
highly susceptible to bias in that the diagnosis has to be correctly made, recorded and transcribed 
into the appropriate record. Estimated rates of accurate dementia reporting on death certificates 
are 25-58%110, 119 but more recent studies suggest that this is improving, for example in a cohort 
of 502 deceased individuals with probable AD 359 (71.5%) had dementia correctly recorded as a 
cause of death.120 Furthermore there is a potential spatial confounder in that clinical service 
provision or quality may vary with geography, resulting in variation of dementia prevalence as in 
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one study where 43% cases in a cluster could be linked back to just one clinician, who 
presumably had a particular interest in dementia.63 
 
More robust are screening studies, particularly two-stage screening designs and especially when 
the whole population is screened rather than a sample. However, there is still danger of selection 
bias creeping in.111 The best quality studies included were the Neurologic Disorders in Central 
Spain study19 and, despite numerous methodological challenges—including estimating the ages of 
some of the Yoruba interviewed—the Ibadan-Indianapolis study.35, 36, 42, 43 Both studies showed 
variation in dementia incidence and the latter showed variation in AD prevalence. 
 
The cultural validity of tests and rating scales, even if translated, is often unclear. Furthermore, 
cultural factors related to ageing and functional decline are also highly relevant to variation and a 
source of bias. Different cultures react to and accommodate ageing in different ways and will 
treat symptoms of cognitive and functional decline differently. We must not ignore the implicit 
value-laden nature of many, if not all, diagnoses,121 even dementia—for example what level of 
functioning can be expected at what age—and the variation of these values in different countries 
and different cultures. In fact, from a global perspective, the individual with dementia may not be 
a fixed kind of person but what Hacking describes as a “moving target.”122 
 
Further potential confounders include differential survival or migration—for example, if 
individuals at highest risk of developing dementia in an area die or move away, those remaining 
will have an artefactually low prevalence of dementia. Both migration61 and differential survival35, 
36, 42, 43, 61 were considered by a small number of the studies. The methodology most susceptible to 
bias by migration is comparing country of birth of individuals living in a discrete geographical 
area. That the finding that risk of dementia is increased in people born in Africa or the 
Caribbean50, 54 is not matched by increased rates of dementia in these countries suggests that 
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migration may have confounded the studies using this methodology. Similarly genetic relatedness 
is a factor which must be taken into account and was estimated by some of the studies 
included.61, 103, 104, 123 
 
The spatial variable must also be recorded for a sufficiently early point in life to avoid reverse 
causality, for example mapping the location of death of people with dementia may merely identify 
the locations of care homes or hospitals with long-stay beds.110  
 
The relative dearth of larger-scale comparisons—for example regions, towns or postal districts—
limits the precise assessment of any variation which might be found and thus the conclusions 
which can be drawn about possible socio-environmental exposures. 
 
This review explicitly excluded papers comparing studies conducted independently or with 
different methodologies. Therefore there are potentially further studies looking, for example, at 
rates of dementia in rural areas, but the methodological difficulties in combining these with 
separate studies preclude such a comparison. This criterion is unlikely to have introduced 
substantial bias but clearly reduces the data available substantially with a consequent impact on 
confidence intervals for effect estimates. 
 
Implications 
Apart from implications for health service provision, the real interest in identifying variation in 
the prevalence and incidence of a disease is in identifying potentially modifiable risk factors. 
Many socio-environmental risk factors are likely to have their effect on dementia risk early in 
life,124-126 though not all studies confirm this association.127 Some of studies included in the 
current review examined early life effects, for example place of birth61 or living in a rural area in 
childhood,42, 43 but the majority measured their exposures at the time of the study. The 
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rural/urban meta-analysis suggested that, while rural living may be associated with increased rates 
of AD, early life rural living may have an even greater effect. There are two possible implications 
of this finding—that exposure in early life has a greater effect or that duration of exposure 
determines the risk. Further research is required to clarify this finding. 
 
However any consideration of geographical variation of dementia must also include geographical 
variation of related conditions and risk factors. Cardiovascular and cerebrovascular disease has 
been shown to vary in incidence across Scotland and this variation is partly related to smoking (in 
both sexes) and populations density, deprivation, blood pressure and body mass index (in 
men).100 Temporal trends are also important. The possibility that changes in dementia incidence 
over time, and some geographical variation, might be related to improved survival following 
stroke has been raised.128, 129 Detailed examination of secular trends in dementia, related 
conditions, and risk factors is required.130 
 
Given the early effects of some risk-factors and the presence of pathological changes of AD 
decades before the clinical onset of dementia,131 any attempts at prevention will need to begin 
sufficiently early in life. A number of systematic reviews have shown that modifying risk factors 
in late life, for example lowering blood pressure132 or treatment with statins,133 are ineffective in 
preventing dementia, consistent with the evidence that many risk factors for dementia have their 
effects in mid-life or earlier.134-137  
 
This need for sufficiently early intervention is reflected in the ideal methodology of dementia 
epidemiology studies and the importance of measuring risk factors—including location—at the 
most appropriate time point. Identification of any putative risk factors, at any geographical scale, 
requires their measurement to be at a sufficiently early stage for the findings to be clinically 
meaningful. 
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Conclusions 
Though the extant evidence is far from consistent and varies in quality, prevalence and incidence 
of dementia does vary, at a number of scales: between countries, regions, towns and cities, and 
small areas. There is weak evidence for variation in dementia incidence or prevalence between 
rural and urban areas but stronger evidence for AD and vascular dementia. Furthermore, early 
exposure to rural living may have an increased effect on the association between rurality and AD.  
 
Further work to provide higher quality evidence of geographical and temporal variation is 
required and comparisons could usefully be made with the geographical distributions of related 
conditions, such as stroke and cardiovascular disease. The next question is whether the causes of 
this observed variation can be identified and, if so, could they highlight modifiable socio-
environmental risk factors thus making dementia a preventable disease? 
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Table 1. Databases searched and dates of searches 
Database Database start Date searched 
ASSIA - Applied Social Science Index 1987 8/4/10 
Embase 1974 8/4/10 
FRANCIS 1984 8-9/4/10 
GEOBASE 1980 8/4/10 
Global Health  1973 9/4/10 
Lilacs 1982 9/4/10 
Medline 1950 8/4/10 
PsycINFO 1806 8/4/10 
CINAHL 1981 8/4/10 
COPAC 1100 14/4/10 
Scielo 1997 14/4/10 
Ethos British Library these service — 14/4/10 
Australian Digital Theses Progam (ADT) 1998 14/4/10 
Index to theses — 14/4/10 
ProQuest Dissertations and Theses 1861 15/4/10 
Theses Canada Portal 1965 15/4/10 
Conference Papers Index  — 15/4/10 
PapersFirst 1993 15/4/10 
ProceedingsFirst  1993 15/4/10 
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Table 2. Studies meeting inclusion criteria: Country-country comparisons or surveys comparing country of birth 
Author Year Study Setting Methods Measures Diagnostic 
Criteria 
Participants Ages Total 
N 
Cases 
 
Quality (A–E) 
Anzola-Perez et 
al 
1996 PAHO 
study 51 
Argentina, 
Chile & 
Cuba 
One-phase 
survey 
Spanish 
MMSE 
MMSE score Age- and sex-
stratified random 
community samples 
≥60 3 211 variable D Methodologies differ slightly 
Cristina et al 
Román 
 
1997 
1998 
“COLOM
BO 2000” 
project 64, 
88 
Argentina & 
Italy 
Death 
certificate data 
— Not stated All AD deaths Not 
defined 
90.8 
million 
Not 
stated 
E Relies on diagnosis being 
recorded; Population age-
structures different 
Livingston et al 2001 Islington 
Study 54 
Islington, 
London 
One-phase 
survey 
Short-CARE 
interview 
Short-CARE Random sample 
stratified by country 
of birth 
≥65 1 085 107 C Good ascertainment; Use of 
place of birth confounds 
migration and other factors 
Figueroa et al 2008 60 USA & 
Puerto Rico 
Death 
certificate data 
— ICD-10 All AD deaths Not 
defined 
Census Not 
stated 
E Relies on diagnosis being 
recorded 
Rodriguez et al 
Sousa et al 
2008 
2009 
10/66 
Dementia 
Research 
Group 23, 
57 
Cuba, 
Dominican 
Republic, 
Peru, 
Venezuela, 
China & 
India 
Cross-sectional 
comprehensive 
one-phase 
surveys 
— 10/66 
criteria 
DSM-IV 
All residents in 
geographically-
defined catchment 
areas 
≥65 14 960 Not 
stated 
B Screening difficulties possible; 
Standardisation between so 
many centres challenging 
Adelman et al 2011 50 Haringey, 
London 
Two-phase 
survey 
MMSE 
CAMCOG 
ICD-10 
DSM-IV-TR 
Consensus 
criteria for 
sub-types 
Random sample of 
GP lists stratified by 
recorded ethnic 
group/birth country 
≥60 666 36 C Robust design but spatial 
variable is confounded by 
migration 
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Table 3. Studies meeting inclusion criteria: Rural/Urban comparisons (Articles in italic also appear in another table) 
Author Year Study Setting Methods Measures Diagno
stic 
Criteria 
Participants Ages Total N Cases Quality (A–E) 
Leighton et al 1963 22 Nigeria: Yoruba 
villages and Abeokuta 
town 
Population 
survey 
— not 
stated 
People with ‘chronic 
brain syndrome’ 
Not 
define
d 
326 ~17 E unclear 
Imaizumi 1992 20 Japan Death 
certificate data 
— ICD-9 All AD deaths ≥35 Total 
population 
931 E Relies on diagnosis being 
recorded 
Emard et al 
Perron et al 
Jean et al 
1992 
1993 
1996 
Projet 
IMAGE 
66, 67, 71 
Saguenay-Lac-Saint-
Jean territory, Québec, 
Canada 
Case register Reisberg GDS 
Screening 
Clinical assessment 
Adapted 
NINCDS
-ADRDA 
AD cases Not 
define
d 
131 667 
live 
births 
235 C Dependent on quality of case 
register; case ascertainment 
and representativeness of 
sample unclear; differential 
mortality a potential bias 
Ebly et al 
Manfreda 
Hébert et al 
1994 
1995 
2000 
Canadian 
Study of 
Health & 
Aging 33, 
34, 39 
All ten provinces of 
Canada 
Two-phase 
screening 
Incidence 
study (5 years) 
3MS 
Clinical assessment 
(including all 
institutionalised 
individuals) 
Not 
stated 
Random sample 
from community 
and institutionalised 
residents 
≥65 6 449 97 B Robust design but 
ascertainment unclear 
Yip et al 1997 49 Taiwan: Ta-an district 
(urban) and Chin-shan 
Hsiang (rural) 
Multi-phase 
survey 
Chinese MMSE 
ADL scales 
Clinical assessment 
DSM-
III-R 
Random sample of 
community stratified 
by age 
≥65 1 733 29 C Relatively robust but different 
response rates: 90 vs 71% 
Liu et al  
Lin et al 
1997 
1998 
38 
37 
Southern Taiwan Two-phase 
screening  
Chinese MMSE  
Blessed DRS 
Clinical assessment 
ICD-10-
NA 
Random sample 
stratified by rurality 
≥65 2 915 108 B Reasonable design 
Azzimondi et al 1998 30 Sicily, Italy: Troina 
(isolated & rural) and 
S. Agata Militelo (a 
more developed small 
town) 
Two-phase 
screening 
Italian MMSE 
Clinical assessment 
Not 
stated 
50% random sample ≥75 773 196 E No power calculation and no 
statistical comparisons; 
clinical assessment only of 
sample of borderline cases, 
not all who screened negative 
Table 3 continues on the next page. 
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Table 3 continued 
Author Year Study Setting Methods Measures Diagnostic 
Criteria 
Participants Ages Total N Cases Quality (A–E) 
MRC CFAS 
Matthews et al 
Brayne et al 
1998 
2005 
2006 
MRC CFAS 
31, 40, 41 
UK: Four urban 
and two rural 
areas 
Two-phase 
screening 
Incidence 
study (2 
years) 
GMS 
AGECAT 
MMSE 
GMS Assessment 
CAMCOG 
Not 
stated 
Stratified random 
community sample 
≥65 17 751 
(prevalence) 
7 175 
(incidence) 
630 
incident 
B Robust design; unreported measures; 
two-fold variation in prevalence 
reasonable 
Hendrie et al 
Ogunniyi et al 
1995 
2000 
Ibadan-
Indianapolis 
Study 36, 42 
Ibadan, Nigerian 
and Indianapolis, 
USA 
Two-phase 
screening 
 
CSID 
Clinical 
assessment 
DSM-
IIIR and 
ICD-10 
 
Community-dwelling 
Yoruba or sample of 
African Americans 
living in the community 
or in 6 representative 
nursing homes 
≥65 5 117 165 A Robust, identical methodologies 
Hendrie et al 
Ogunniyi et al 
2001 
2006 
Ibadan-
Indianapolis 
Study 35, 43 
Ibadan, Nigerian 
and Indianapolis, 
USA 
Incidence 
study (2 and 
5 years) 
Two-phase 
screening 
CSID 
Clinical 
assessment 
DSM-
IIIR and 
ICD-10 
 
Community-dwelling 
Yoruba or African 
Americans 
≥65 4 606 187 A Robust, identical methodologies 
Zhang et al 
Zhang et al 
2005 
2006 
46, 47 Four regions of 
China 
Two-phase 
screening 
Chinese 
MMSE 
Clinical 
assessment 
Re-
examination at 
6 months 
DSM-IV 
ICD-10 
Stratified, multistage, 
cluster random sample 
from census 
≥55 34 807 1 027 B Thorough case-finding and 80-90% 
follow up; crude prevalences 
reported 
Bermejo-Pareja 
et al 
2008 Neurologic 
Disorders in 
Central 
Spain 19 
Spain: Las 
Margaritas, greater 
Madrid (working 
class), Lista, central 
Madrid 
(professional class) 
& Arévalo 
(agricultural) 
Two-phase 
screening 
Incidence 
study (3 
years) 
Spanish 
MMSE 
Pfeffer 
activities 
questionnaire 
Clinical 
assessment 
Consensu
s 
DSM-IV 
Census data for 
geographically-defined 
areas 
≥65 5 914 
(prevalence) 
3 891 
(incidence) 
306 
prevalent 
161 
incident 
A Robust methodology 
Rodriguez et al 
Sousa et al 
2008 
2009 
10/66 
Dementia 
Research 
Group 23, 57 
Cuba, 
Dominican 
Republic, Peru, 
Venezuela, 
China & India 
Cross-
sectional 
comprehensi
ve one-
phase 
surveys 
— 10/66 
criteria 
DSM-IV 
All residents in 
geographically-defined 
catchment areas 
≥65 14 960 Not 
stated 
B Screening difficulties possible; 
Standardisation between so many 
centres challenging 
ArslantaŞ et al 2009 21 Eskisehir city, 
Middle Anatolia, 
Turkey 
Two-phase 
screening 
Turkish 
MMSE 
Clinical 
assessment 
Not 
stated 
Random cluster 
sample of 
geographically-defined 
areas 
≥55 3 100 262 D Relatively robust methodology but 
49.5% who failed MMSE declined 
further assessment and no one with 
MMSE >25 was assessed further 
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Table 4. Studies meeting inclusion criteria: Regional comparisons 
Author Year Study Setting Methods Measures Diagnostic 
Criteria 
Participants Ages Total 
N 
Cases Quality (A–E) 
Sulkava et al 
Sulkava et al 
1985 
1988 
Mini-
Finland44, 
45 
Finland Two-phase 
screening 
Cattel’s G-factor test 
Verbal memory test 
Clinical assessment 
DSM-III Representative 
sample of Finnish 
population 
≥30 
(≥75 for 
dementia 
project) 
8 000 141 B Robust design and representative 
sample. 
Jorm et al 1989 63 Six 
Australian 
states 
Death 
certificate 
data 
— ICD-9 All deaths 1979-85 Not 
defined 
— — E Depends on dementia being reported 
Zhang et al 1990 Guam 72 Guam, 
Mariana 
Islands, 
NW 
Pacific 
Case register Direct standardisation 
of incidence rates 
using 1960 Chamorro 
population age 
distribution 
Neuropatho
logical and 
clinical 
criteria90 
All cases of 
Parkinsonism-
Dementia complex 
Not 
defined 
Not 
stated 
Not 
stated 
C Completeness of case register may 
vary with time and location 
Imaizumi 1992 20 Japan Death 
certificate 
data 
— ICD-9 All AD deaths ≥35 Total 
popula
tion 
931 E Relies on diagnosis being recorded 
CSH&A 
Working 
Group 
Ebly et al 
Manfreda 
1994 
 
 
1994 
1995 
Canadian 
Study of 
Health & 
Aging32, 33, 
39 
Five 
Canadian 
provinces 
Two-phase 
screening 
3MS 
Clinical assessment 
(including all 
institutionalised 
individuals) 
DSM-III Random sample 
from community 
and 
institutionalised 
residents  
≥65 10 263 
(2 896) 
1 125 
(515) 
B Robust design but ascertainment 
unclear; Ebly et al (1994) only 
included over-85s—in brackets33 
Hébert et al 2000 Canadian 
Study of 
Health & 
Aging 34 
All ten 
Canadian 
provinces 
Two-phase 
screening 
Incidence 
study (5 
years) 
3MS 
Clinical assessment 
(including all 
institutionalised 
individuals) 
DSM-III 
(Vascular 
dementia) 
Random sample 
from community 
and 
institutionalised 
residents 
≥65 6 449 97 B Robust design but ascertainment 
unclear 
White et al 1994 Epidemiol
ogic 
Studies of 
the 
Elderly59 
USA: East 
Boston, 
Iowa & 
New 
Haven 
One-phase 
survey 
Incidence 
study (3 and 
6 years) 
Short Portable MSQ SPMSQ ≥ 3 
ICD-9 
Community 
population 
≥65 9 174 Not 
stated 
E Methods unclear, comparability 
questionable 
Table 4 continues on the next page. 
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Table 4 continued 
Author Year Study Setting Methods Measures Diagnostic 
Criteria 
Participants Ages Total N Cases Quality (A–E) 
MRC CFAS 
Matthews et al 
Brayne et al 
1998 
2005 
2006 
MRC CFAS 31, 
40, 41 
UK: Four urban and 
two rural areas 
Two-phase 
screening 
Incidence 
study (2 
years) 
GMS AGECAT 
MMSE 
GMS assessment 
 Stratified random 
community 
sample 
≥65 17 751 
(prevalence) 
7 175 
(incidence) 
630 
incident 
B Robust design; 
unreported measures; 
two-fold variation in 
prevalence reasonable 
Hendrie et al 1993 48 Canada: Two Cree 
reserves in Northern 
Manitoba and 
Winnipeg 
Two-phase 
screening 
Initial interview 
Clinical 
assessment 
(culturally 
adapted) 
DSM-III-R All registered Cree 
Winnipeg: age-
stratified sample 
from Health 
Insurance 
database  
≥65 
(over-
sampling of 
≥80s in 
Winnipeg) 
468 31 C Comprehensive Cree 
register and reasonably 
comparable 
population, though 
institutional sample 
included; screening 
sensitive 
Zhang et al 
Zhang et al 
2005 
2006 
46, 47 Four regions of 
China 
Two-phase 
screening 
Chinese MMSE 
Clinical 
assessment 
Re-examination 
at 6 months 
DSM-IV 
ICD-10 
Stratified, 
multistage, cluster 
random sample 
from census 
≥55 34 807 1 027 B Thorough case-finding 
and 80-90% follow up; 
crude prevalences 
reported 
Laditka et al 
Laditka et al 
Laditka et al 
2008 
2006 
2006 
68-70 South Carolina, USA Case register — ICD-9-CM AD cases not 
defined 
US  
Census 
~33 754 B Very robust 
methodology but 
unclear when spatial 
analysis conducted (i.e. 
birth, adulthood etc.) 
Figueroa et al 2008 60 USA & Puerto Rico Death 
certificate 
data 
— ICD-10 All AD deaths not 
defined 
Census Not 
stated 
E Relies on diagnosis 
being recorded 
Bermejo-
Pareja et al 
2008 Neurologic 
Disorders in 
Central Spain 
19 
Spain: Las 
Margaritas, greater 
Madrid (working 
class), Lista, central 
Madrid (professional 
class) & Arévalo 
(agricultural) 
Two-phase 
screening 
Incidence 
study (3 
years) 
Spanish MMSE 
Pfeffer activities 
questionnaire 
Clinical 
assessment 
DSM-IV Census data for 
geographically-
defined areas 
≥65 5 914 
(prevalence) 
3 891 
(incidence) 
306 
prevalent 
161 
incident 
A Robust methodology 
Steenland et al 2009 29 USA 
1999-2004 
Death 
certificate 
data 
— ICD-10 All AD deaths not 
defined 
1.7 
billion 
336 232 E Relies on diagnosis 
being recorded 
Gillum et al 2011 65 USA Death 
certificate 
data 
— ICD-10 All AD deaths 
1999-2000 and 
2005-6 
Not 
defined 
Not 
stated 
555 904 
dementia 
211 386 
AD 
E Relies on diagnosis 
being recorded 
 43 
Table 5. Studies meeting inclusion criteria: Town/city comparisons 
Author Year Study Setting Methods Measures Diagnosti
c Criteria 
Participants Ages Total 
N 
Cases Quality (A–E) 
Gurland et al 1979 US-UK 
Geriatric 
Community 
Study 28 
New York and 
London 
One-phase survey MSQ 
CARE interview 
(modified) 
MSQ ≥ 8 Random sample of elderly 
in institutions 
not 
defined 
321 ~117 C Reasonable methodology; 
small study 
Ichinowatari 
et al 
1987 53 Japan: Sashiki 
village and 
Ikema Island, 
Okinawa 
One-phase survey  
One year of follow 
up for confirmation 
Not stated ICD-9 Over-65s clinically 
diagnosed with dementia 
≥65 919 45 A Clinical assessment of 
entire populations 
Copeland et al 1987 US-UK 
Cross-
National 
(Diagnostic) 
Project 52 
New York and 
London 
One-phase survey GMS AGECAT AGECAT 
DSM-III 
(London 
only) 
New York: random cluster 
sample 
London: random sample 
from 3 000 GPs 
≥65 841 — C Validity depends on 
AGECAT; DSM-III 
diagnosis confirms 
AGECAT diagnosis in 
London sample 
Lobo 
Lobo et al 
1990 
1992 
55, 56 Zaragoza, 
Spain and 
Liverpool, UK 
One-phase survey  GMS AGECAT AGECAT Random age-stratified 
sample from census 
(Spain) or GP lists (UK) 
≥65 2 620 134 D Unclear if comparison is 
an a priori hypothesis; 
random sampling 
subverted in Spain 
Hendrie et al 
Ogunniyi et al 
1995 
2000 
Ibadan-
Indianapolis 
Study 36, 42 
Ibadan, 
Nigerian and 
Indianapolis, 
USA 
Two-phase screening 
 
CSID 
Clinical assessment 
DSM-IIIR 
and 
ICD-10 
 
Community-dwelling 
Yoruba (total population 
survey of geographically-
defined area) or African 
Americans living in the 
community (60% sample) 
or in 6 representative 
nursing homes 
≥65 5 117 165 A Robust, identical 
methodologies 
Hendrie et al 
Ogunniyi et al 
2001 
2006 
Ibadan-
Indianapolis 
Study 35, 43 
Ibadan, 
Nigerian and 
Indianapolis, 
USA 
Incidence study (2 
and 5 years) 
Two-phase screening 
CSID 
Clinical assessment 
DSM-IIIR 
and ICD-
10 
 
Community-dwelling 
Yoruba or African 
Americans 
≥65 4 606 187 A Robust, identical 
methodologies 
Artero et al 2003 3C Study 58 France: 
Bordeaux 
(SW), Dijon 
(NE) & 
Montpellier 
(SE) 
One-phase survey 
Incidence study (2 
and 4 years) 
Cognitive battery 
Clinical assessment 
(sample in Dijon) 
DSM-IV Random sample of non-
institutionalised over-65s 
≥65 9 693 ~637 C Reasonable methodology; 
in Dijon, screening 
estimated to be 87.5% 
sensitive and 78.8% 
specific 
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Table 6. Studies meeting inclusion criteria: Small area comparisons 
Author Year Study Setting Methods Measures Diagnostic 
Criteria 
Participants Ages Total 
N 
Cases Quality (A–E) 
Frecker 1991 61 Newfoundland, 
Canada 
Death certificate data 
and case note 
scrutiny 
— not stated All deaths mentioning 
dementia 1985-6 
not 
defined 
7 238 399 C Relies on diagnosis being 
recorded or sufficient 
information in case notes; very 
robust otherwise including 
controls for sex and survival 
biases 
Emard et al 
Perron et al 
Jean et al 
1992 
1993 
1996 
Projet 
IMAGE 
66, 67, 71 
Saguenay-Lac-
Saint-Jean 
territory, 
Québec, Canada 
Case register Reisberg 
GDS 
Screening 
Clinical 
assessment 
Adapted 
NINCDS-
ADRDA 
AD cases not 
defined 
131 667 
live 
births 
235 C Dependent on quality of case 
register; case ascertainment 
and representativeness of 
sample unclear; differential 
mortality a potential bias 
Huss et al 2009 62 Switzerland Death certificate data 
linked to census 
— ICD-10 Community-dwellers ≥30 4.65 
million 
45 716 D Relies on diagnosis being 
recorded 
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Figure 1. PRISMA diagram showing selection of studies for inclusion in systematic review of geographical clustering of dementia prevalence and incidence 
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Figure 2. Comparison of standardised dementia prevalence (95% CI) with different diagnostic 
criteria. Constructed from 10/66 Dementia Research Group data.23 
 
DR = Dominican Republic, U = Urban, R = Rural. 
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Figure 3. Meta-analysis with forest plot of urban/rural differences in dementia prevalence (Reference 23 using DSM-IV criteria).  
 
Rural+: dementia cases in rural areas; Rural-: non-dementia cases in rural areas; Urban+: dementia cases in urban areas; Urban-: non-dementia cases in 
urban areas. Articles without case numbers reported odds ratios and 95% CIs rather than raw numbers. Urban areas form the referent.
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Figure 4. Meta-analysis with forest plot of urban/rural differences in dementia incidence.  
 
Rural+: dementia cases in rural areas; Rural-: non-dementia cases in rural areas; Urban+: dementia cases in urban areas; Urban-: non-dementia cases in 
urban areas. Articles without case numbers reported odds ratios and 95% CIs rather than raw numbers. Urban areas form the referent.  
